Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society.

[1]  P. Jones,et al.  Health status measurement in chronic obstructive pulmonary disease , 2001, Thorax.

[2]  E. Barreiro,et al.  Structural and functional changes in the skeletal muscles of COPD patients: the "compartments" theory. , 2001, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[3]  J. Gea,et al.  Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. , 2001, The European respiratory journal.

[4]  M. Polkey,et al.  Quadriceps muscle weakness following acute hemiplegic stroke , 2001, Clinical rehabilitation.

[5]  E. Wouters,et al.  Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. , 2001, The European respiratory journal.

[6]  A. Goris,et al.  Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. , 2000, Respiratory medicine.

[7]  M. Decramer,et al.  Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. , 2000, The American journal of medicine.

[8]  J. Vestbo,et al.  Prognostic value of nutritional status in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[9]  R. Casaburi.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease. , 1999, Medicine and science in sports and exercise.

[10]  F. Maltais,et al.  Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. , 1998, Journal of cardiopulmonary rehabilitation.

[11]  F. Maltais,et al.  Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[12]  L. Kaiser,et al.  Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. , 1997, The New England journal of medicine.

[13]  C. Pichard,et al.  Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. , 1997, American journal of respiratory and critical care medicine.

[14]  R. Zuwallack,et al.  Body composition and health-related quality of life in patients with obstructive airways disease. , 1997, The European respiratory journal.

[15]  M. Decramer,et al.  Muscle weakness is related to utilization of health care resources in COPD patients. , 1997, The European respiratory journal.

[16]  M. Decramer,et al.  Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[17]  M. Decramer,et al.  Peripheral muscle weakness contributes to exercise limitation in COPD. , 1996, American journal of respiratory and critical care medicine.

[18]  P. Macklem,et al.  Nutritional status and mortality in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[19]  N. Jones,et al.  Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. , 1995, American journal of respiratory and critical care medicine.

[20]  M. Polkey,et al.  Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man , 1995, Muscle & nerve.

[21]  J. Mege,et al.  Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[22]  E. Wouters,et al.  Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. , 1994, The European respiratory journal.

[23]  E. Wouters,et al.  Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.

[24]  N. Jones,et al.  Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. , 1992, The American review of respiratory disease.

[25]  N. Jones,et al.  Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. , 1992, Thorax.

[26]  K. Westerterp,et al.  Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. , 1991, The American journal of clinical nutrition.

[27]  L. Jorfeldt,et al.  Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. , 1990, The European respiratory journal.

[28]  N. Anthonisen,et al.  Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. , 1989, The American review of respiratory disease.

[29]  D. Jones,et al.  Human skeletal muscle function: description of tests and normal values. , 1977, Clinical science and molecular medicine.

[30]  K. P. Van de Woestijne,et al.  Weight changes in the terminal stages of chronic obstructive pulmonary disease. Relation to respiratory function and prognosis. , 1967, The American review of respiratory disease.

[31]  B. M. Lewis,et al.  FACTORS AFFECTING PROGNOSIS IN EMPHYSEMA. , 1964, Diseases of the chest.

[32]  T. L. Davies,et al.  Diseases of the lungs. , 1948, Lancet.

[33]  E. Wouters,et al.  Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease , 1998 .